EXETER, UNITED KINGDOM, February 10, 2026 /EINPresswire.com/ — Attomarker, a UK-based diagnostics company, today announced that it has commenced an Acceleration ...
A new COVID-19 Triple Antibody Test, produced by Attomarker Ltd, a spin-out company from the University of Exeter, could represent the next-generation of rapid and accurate COVID-19 antibody testing.
(MENAFN- EIN Presswire) EINPresswire/ -- EpitogenX Ltd and Attomarker Ltd have announced the signing of a strategic co-development agreement that unites their complementary strengths in ...
The Acceleration Round is intended to support commercial rollout, regulatory progress, further clinical validation, and extension of Attomarker’s immune profiling portfolio within Long Covid.” — ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results